nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—MPO—C-MYB transcription factor network—SLC25A3—salivary gland cancer	0.066	0.066	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—ITGB4—salivary gland cancer	0.0368	0.0368	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—DAPK1—salivary gland cancer	0.0368	0.0368	CbGpPWpGaD
Tolmetin—CXCL8—Syndecan-3-mediated signaling events—FGFR4—salivary gland cancer	0.0315	0.0315	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—CRTC1—salivary gland cancer	0.0277	0.0277	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—SMARCA2—salivary gland cancer	0.0274	0.0274	CbGpPWpGaD
Tolmetin—TDO2—Amino acid and derivative metabolism—PHGDH—salivary gland cancer	0.0263	0.0263	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—KRT5—salivary gland cancer	0.0262	0.0262	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—KRT14—salivary gland cancer	0.0244	0.0244	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—EN1—salivary gland cancer	0.0226	0.0226	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—KRT14—salivary gland cancer	0.0222	0.0222	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—SLC25A3—salivary gland cancer	0.0214	0.0214	CbGpPWpGaD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—FGFR4—salivary gland cancer	0.0205	0.0205	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—MYB—salivary gland cancer	0.0192	0.0192	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—KDM6B—salivary gland cancer	0.018	0.018	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—MYB—salivary gland cancer	0.0164	0.0164	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—MAP2K2—salivary gland cancer	0.0156	0.0156	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—HIST1H1E—salivary gland cancer	0.0149	0.0149	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—VCAN—salivary gland cancer	0.0139	0.0139	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—KDM6B—salivary gland cancer	0.0136	0.0136	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—AQP1—salivary gland cancer	0.013	0.013	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—BRCA1—salivary gland cancer	0.0119	0.0119	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—CDH1—salivary gland cancer	0.0115	0.0115	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—HIST1H1E—salivary gland cancer	0.0112	0.0112	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—MAP2K2—salivary gland cancer	0.0112	0.0112	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—CYLD—salivary gland cancer	0.0103	0.0103	CbGpPWpGaD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.0102	0.0102	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—VCAN—salivary gland cancer	0.0102	0.0102	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—MC3R—salivary gland cancer	0.0101	0.0101	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—SMARCA2—salivary gland cancer	0.0089	0.0089	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—MYB—salivary gland cancer	0.00866	0.00866	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—CCND1—salivary gland cancer	0.0086	0.0086	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ISYNA1—salivary gland cancer	0.0078	0.0078	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—salivary gland cancer	0.00747	0.00747	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—CREBBP—salivary gland cancer	0.00706	0.00706	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—salivary gland cancer	0.00687	0.00687	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—PIK3CA—salivary gland cancer	0.00685	0.00685	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.0068	0.0068	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—FOXO3—salivary gland cancer	0.00658	0.00658	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—MARCKS—salivary gland cancer	0.00636	0.00636	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—MYB—salivary gland cancer	0.00623	0.00623	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—MAP2K2—salivary gland cancer	0.00603	0.00603	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PYGB—salivary gland cancer	0.00591	0.00591	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—AQP1—salivary gland cancer	0.00568	0.00568	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—TP53—salivary gland cancer	0.00567	0.00567	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—ISL1—salivary gland cancer	0.00554	0.00554	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—HRAS—salivary gland cancer	0.00542	0.00542	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—salivary gland cancer	0.0054	0.0054	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—CREBBP—salivary gland cancer	0.00534	0.00534	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—CCND1—salivary gland cancer	0.00522	0.00522	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.0052	0.0052	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—MC3R—salivary gland cancer	0.00518	0.00518	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—CCND1—salivary gland cancer	0.00514	0.00514	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—IGFBP2—salivary gland cancer	0.00501	0.00501	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PHGDH—salivary gland cancer	0.00482	0.00482	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—EP300—salivary gland cancer	0.00481	0.00481	CbGpPWpGaD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—HRAS—salivary gland cancer	0.00481	0.00481	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—EP300—salivary gland cancer	0.00473	0.00473	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—MAP2K2—salivary gland cancer	0.00471	0.00471	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ST3GAL4—salivary gland cancer	0.00464	0.00464	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—CCND1—salivary gland cancer	0.00448	0.00448	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—VCAN—salivary gland cancer	0.00447	0.00447	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—GAS6—salivary gland cancer	0.00447	0.00447	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—PTEN—salivary gland cancer	0.00433	0.00433	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—AQP1—salivary gland cancer	0.00421	0.00421	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—PIK3CA—salivary gland cancer	0.0042	0.0042	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—TP53—salivary gland cancer	0.00417	0.00417	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—EP300—salivary gland cancer	0.00413	0.00413	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—salivary gland cancer	0.00403	0.00403	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—HRAS—salivary gland cancer	0.00376	0.00376	CbGpPWpGaD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.00373	0.00373	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—salivary gland cancer	0.00371	0.00371	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—EP300—salivary gland cancer	0.00364	0.00364	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—ST3GAL4—salivary gland cancer	0.00351	0.00351	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—NUP62—salivary gland cancer	0.00334	0.00334	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—VCAN—salivary gland cancer	0.00331	0.00331	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—HRAS—salivary gland cancer	0.00329	0.00329	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—CREBBP—salivary gland cancer	0.00319	0.00319	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—ATM—salivary gland cancer	0.00319	0.00319	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—PTEN—salivary gland cancer	0.00313	0.00313	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—HRAS—salivary gland cancer	0.00303	0.00303	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00299	0.00299	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—TP53—salivary gland cancer	0.00295	0.00295	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—CCND1—salivary gland cancer	0.00295	0.00295	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—MC3R—salivary gland cancer	0.00293	0.00293	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—FOXO3—salivary gland cancer	0.00288	0.00288	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—MC3R—salivary gland cancer	0.00266	0.00266	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—TP53—salivary gland cancer	0.0026	0.0026	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.00254	0.00254	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	0.00253	0.00253	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—ATM—salivary gland cancer	0.00241	0.00241	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00239	0.00239	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CREBBP—salivary gland cancer	0.00229	0.00229	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—PIK3CA—salivary gland cancer	0.00226	0.00226	CbGpPWpGaD
Tolmetin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—salivary gland cancer	0.00225	0.00225	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.00217	0.00217	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TP53—salivary gland cancer	0.00213	0.00213	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CREBBP—salivary gland cancer	0.00209	0.00209	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—HRAS—salivary gland cancer	0.00204	0.00204	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.00203	0.00203	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—WNT5B—salivary gland cancer	0.00199	0.00199	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TP53—salivary gland cancer	0.00194	0.00194	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL17RD—salivary gland cancer	0.00193	0.00193	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—FBXW7—salivary gland cancer	0.00191	0.00191	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00189	0.00189	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—PIK3CA—salivary gland cancer	0.00176	0.00176	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAML3—salivary gland cancer	0.00176	0.00176	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.00173	0.00173	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CCND1—salivary gland cancer	0.0017	0.0017	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ISYNA1—salivary gland cancer	0.00168	0.00168	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MC3R—salivary gland cancer	0.00157	0.00157	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—EP300—salivary gland cancer	0.00156	0.00156	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00151	0.00151	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—EP300—salivary gland cancer	0.00143	0.00143	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—DTX4—salivary gland cancer	0.00137	0.00137	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.00137	0.00137	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—MARCKS—salivary gland cancer	0.00137	0.00137	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—TP53—salivary gland cancer	0.00135	0.00135	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ISYNA1—salivary gland cancer	0.00133	0.00133	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CREBBP—salivary gland cancer	0.0013	0.0013	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CCND1—salivary gland cancer	0.00129	0.00129	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PYGB—salivary gland cancer	0.00127	0.00127	CbGpPWpGaD
Tolmetin—PTGS2—Disease—WNT5B—salivary gland cancer	0.00125	0.00125	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CPSF4—salivary gland cancer	0.0012	0.0012	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL17RD—salivary gland cancer	0.0012	0.0012	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PYGB—salivary gland cancer	0.0012	0.0012	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.00119	0.00119	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FGF16—salivary gland cancer	0.00114	0.00114	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MAML3—salivary gland cancer	0.0011	0.0011	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—MARCKS—salivary gland cancer	0.00109	0.00109	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—HRAS—salivary gland cancer	0.00107	0.00107	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PHGDH—salivary gland cancer	0.00104	0.00104	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—TP53—salivary gland cancer	0.00102	0.00102	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PYGB—salivary gland cancer	0.00101	0.00101	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ST3GAL4—salivary gland cancer	0.000997	0.000997	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAML2—salivary gland cancer	0.000986	0.000986	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000962	0.000962	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ST3GAL4—salivary gland cancer	0.000946	0.000946	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTEN—salivary gland cancer	0.000925	0.000925	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AQP1—salivary gland cancer	0.000906	0.000906	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—EP300—salivary gland cancer	0.000882	0.000882	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.00088	0.00088	CbGpPWpGaD
Tolmetin—PTGS2—Disease—DTX4—salivary gland cancer	0.000859	0.000859	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TP53—salivary gland cancer	0.000852	0.000852	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000849	0.000849	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—JAG1—salivary gland cancer	0.000842	0.000842	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FGFR4—salivary gland cancer	0.000838	0.000838	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FBXW7—salivary gland cancer	0.000825	0.000825	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PHGDH—salivary gland cancer	0.000823	0.000823	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.00081	0.00081	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ST3GAL4—salivary gland cancer	0.000792	0.000792	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000735	0.000735	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AQP1—salivary gland cancer	0.000719	0.000719	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NUP62—salivary gland cancer	0.000718	0.000718	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—VCAN—salivary gland cancer	0.000713	0.000713	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FGF16—salivary gland cancer	0.00071	0.00071	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FOXO3—salivary gland cancer	0.000696	0.000696	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NUP62—salivary gland cancer	0.000681	0.000681	CbGpPWpGaD
Tolmetin—PTGS2—Disease—VCAN—salivary gland cancer	0.000675	0.000675	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CA—salivary gland cancer	0.000653	0.000653	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000625	0.000625	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MAML2—salivary gland cancer	0.000617	0.000617	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000599	0.000599	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000579	0.000579	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NUP62—salivary gland cancer	0.00057	0.00057	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAP2K2—salivary gland cancer	0.000568	0.000568	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—VCAN—salivary gland cancer	0.000566	0.000566	CbGpPWpGaD
Tolmetin—PTGS2—Disease—JAG1—salivary gland cancer	0.000527	0.000527	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FGFR4—salivary gland cancer	0.000524	0.000524	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FBXW7—salivary gland cancer	0.000516	0.000516	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000496	0.000496	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOTCH1—salivary gland cancer	0.000465	0.000465	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000447	0.000447	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FOXO3—salivary gland cancer	0.000435	0.000435	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000426	0.000426	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CREBBP—salivary gland cancer	0.000422	0.000422	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000396	0.000396	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CA—salivary gland cancer	0.00036	0.00036	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MAP2K2—salivary gland cancer	0.000355	0.000355	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000355	0.000355	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000338	0.000338	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—HRAS—salivary gland cancer	0.000333	0.000333	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000315	0.000315	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCND1—salivary gland cancer	0.000312	0.000312	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTEN—salivary gland cancer	0.000301	0.000301	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOTCH1—salivary gland cancer	0.000291	0.000291	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EP300—salivary gland cancer	0.000287	0.000287	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CREBBP—salivary gland cancer	0.000279	0.000279	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CREBBP—salivary gland cancer	0.000264	0.000264	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.00025	0.00025	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CREBBP—salivary gland cancer	0.000221	0.000221	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CA—salivary gland cancer	0.000213	0.000213	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TP53—salivary gland cancer	0.000206	0.000206	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTEN—salivary gland cancer	0.000199	0.000199	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HRAS—salivary gland cancer	0.000197	0.000197	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—EP300—salivary gland cancer	0.00019	0.00019	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PTEN—salivary gland cancer	0.000189	0.000189	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EP300—salivary gland cancer	0.00018	0.00018	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PTEN—salivary gland cancer	0.000158	0.000158	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—EP300—salivary gland cancer	0.000151	0.000151	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CA—salivary gland cancer	0.00014	0.00014	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CA—salivary gland cancer	0.000133	0.000133	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HRAS—salivary gland cancer	0.000123	0.000123	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CA—salivary gland cancer	0.000111	0.000111	CbGpPWpGaD
